Medulloblastoma in a patient successfully treated for immature teratoma of the ovary.
We report a case of medulloblastoma as a secondary malignancy in a patient treated for immature teratoma of the ovary (ITO). ITO is a rare but curable tumor of the ovary using combination chemotherapy. There is a great deal of interest in the long-term effects of chemotherapy in these patients. Once regarded as fatal not many series of patients with ITO have been reported with the long follow up as in the present case. This case may start a debate on the susceptibility of central nervous system tumors following chemotherapy in patients with ITO.
Yalçin
S
S
Hacettepe University Institute of Oncology, Department of Pathology, Ankara, Turkey.
Güler
N
N
Söylemezoğlu
F
F
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008527:Medulloblastoma / Q000175:diagnosis* / Q000628:therapy; D016609:Neoplasms, Second Primary; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013724:Teratoma / Q000188:drug therapy* / Q000473:pathology